These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 16720867

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Intrahepatic transit time predicts liver fibrosis in patients with chronic hepatitis B: quantitative assessment with contrast-enhanced ultrasonography.
    Li N, Ding H, Fan P, Lin X, Xu C, Wang W, Xu Z, Wang J.
    Ultrasound Med Biol; 2010 Jul; 36(7):1066-75. PubMed ID: 20620694
    [Abstract] [Full Text] [Related]

  • 4. A comparison of 31P magnetic resonance spectroscopy and microbubble-enhanced ultrasound for characterizing hepatitis c-related liver disease.
    Lim AK, Patel N, Eckersley RJ, Fitzpatrick J, Crossey MM, Hamilton G, Goldin RD, Thomas HC, Vennart W, Cosgrove DO, Taylor-Robinson SD.
    J Viral Hepat; 2011 Oct; 18(10):e530-4. PubMed ID: 21914073
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hepatic vein transit times of a microbubble agent in assessing response to antiviral treatment in patients with chronic hepatitis C.
    Lim AK, Patel N, Eckersley RJ, Cobbold JF, Crossey MM, Cosgrove DO, Goldin RD, Thomas HC, Taylor-Robinson SD.
    J Viral Hepat; 2010 Nov; 17(11):778-83. PubMed ID: 20002308
    [Abstract] [Full Text] [Related]

  • 7. Pulmonary transit of echocontrast agents during mechanical ventilation: a clinical transthoracic echocardiographic study.
    Bilotta F, Agati L, Fiorani L, Madonna M, Pinto G, Rosa G.
    Echocardiography; 2005 May; 22(5):395-401. PubMed ID: 15901290
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Does hepatic vein transit time performed with contrast-enhanced ultrasound predict the severity of hepatic fibrosis?
    Tang A, Kim TK, Heathcote J, Guindi M, Jang HJ, Karshafian R, Burns PN, Wilson SR.
    Ultrasound Med Biol; 2011 Dec; 37(12):1963-9. PubMed ID: 22033130
    [Abstract] [Full Text] [Related]

  • 12. Application of the Hepatic Transit Time (HTT) in Evaluation of Portal Vein Pressure in Gastroesophageal Varices Patients.
    Lin YQ, Jiang B, Li HQ, Jin CX, Wang H.
    J Ultrasound Med; 2019 Sep; 38(9):2305-2314. PubMed ID: 30609088
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent.
    Albrecht T, Blomley MJ, Cosgrove DO, Taylor-Robinson SD, Jayaram V, Eckersley R, Urbank A, Butler-Barnes J, Patel N.
    Lancet; 1999 May 08; 353(9164):1579-83. PubMed ID: 10334257
    [Abstract] [Full Text] [Related]

  • 18. Diagnosis of liver cirrhosis by transit-time analysis at contrast-enhanced ultrasonography.
    Abbattista T, Ridolfi F, Ciabattoni E, Marini F, Bendia E, Brunelli E, Busilacchi P.
    Radiol Med; 2008 Sep 08; 113(6):860-74. PubMed ID: 18587531
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [A comparative study of the hepatic transit time (HTT) of different ultrasound contrast agents in patients with liver metastases and healthy controls].
    Haendl T, Strobel D, Neureiter D, Esser K, Frieser M, Hahn EG, Bernatik T.
    Ultraschall Med; 2010 Dec 08; 31(6):582-8. PubMed ID: 20183780
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.